Publications by authors named "Honglan Pei"

Claim this Profile
T
Targeting epidermal growth factor receptor in paclitaxel-resistant human breast and lung cancer cells with upregulated glucose-6-phosphate dehydrogenase.
Hye-Young Min, Ho Jin Lee, Young-Ah Suh, Honglan Pei, Hyukjin Kwon

Br J Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the phenylpyrazolo[3,4-]pyrimidine-based, insulin-like growth factor receptor/Src/AXL-targeting small molecule kinase inhibitor.
Ho Jin Lee, Phuong Chi Pham, Honglan Pei, Bumhee Lim, Seung Yeob Hyun

Theranostics· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70.
Seung Yeob Hyun, Huong Thuy Le, Hye-Young Min, Honglan Pei, Yijae Lim

Theranostics· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ATF6-EGF Pathway Mediates the Awakening of Slow-Cycling Chemoresistant Cells and Tumor Recurrence by Stimulating Tumor Angiogenesis.
Jaebeom Cho, Hye-Young Min, Honglan Pei, Xuan Wei, Jeong Yeon Sim

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent Anticancer Effect of the Natural Steroidal Saponin Gracillin Is Produced by Inhibiting Glycolysis and Oxidative Phosphorylation-Mediated Bioenergetics.
Hye-Young Min, Honglan Pei, Seung Yeob Hyun, Hye-Jin Boo, Hyun-Ji Jang

Cancers (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis